Table 1.

Reported prevalence of FGFR3-TACC3 in human glioma.

Original Article	Prevalence of FGFR3-TACC3 Fusion	Reference
Singh at al.	2.1%	[10]
Di Stefano et al.	2.9%	[76]
Parker et al.	8.3%	[31]
Bao et al.	5.1%	[79]
Asif et al.	11.8%	[78]
Na et al.	1.3%	[77]
Mata et al.	4.1%	[60]
Yoshihara et al.	4.4%	[59]
Ferguson et al.	2.6%	[58]
Schnitthelm et al.	2.3%	[80]
Di Stefano et al.	2.5%	[81]